Tag:
Epixis
Latest Headlines
Latest Headlines
VBI snares next-gen VLP tech in Epixis buyout
A French biotech that has earned some global attention for its early-stage work on a hepatitis C vaccine has revealed the name of its mystery buyer. Cambridge, MA-based VBI is acquiring Epixis for an
Epixis' hep C vaccine shows early promise
French biotech company Epixis says it's used its experimental hepatitis C vaccine to fight off a variety of hepatitis C viruses in animal trials by spawning neutralizing antibodies. The developer is
Fledgling French biotech touts success of new hep C vaccine
A fledgling French biotech which is reportedly being snapped up by an unidentified U.S. drug developer finds itself in the spotlight this morning. Epixis holds the rights to an experimental hepatitis
